JPMorgan Is About to Report Q1 Earnings Tomorrow. Options Traders Are Expecting a 3.87% Move in JPM Stock

JPMorgan is set to report Q1 2026 EPS of $5.45, up 7% year over year, while revenue is expected to fall 8% to $49.13 billion. Investors are focused on AI spending, geopolitical risk from the Iran conflict, and whether volatility pressures capital markets revenue, NII, and credit quality. Options imply a 3.87% post-earnings move, above the 2.71% average move over the past four quarters.

Analysis

The setup is less about JPM’s headline print than about whether management can keep the market focused on earnings durability while steering around three pressure points: funding costs, capital markets cyclicality, and credit normalization if energy prices stay elevated. In a tape where bank multiples are being de-rated for macro uncertainty, the bar is now not “beat estimates,” but “prove the earnings base is resilient enough to justify a premium multiple despite AI capex and geopolitics.” That makes this release a high-leverage sentiment event for the entire money-center cohort, not just JPM.

The second-order winner, if JPM stabilizes guidance, is Goldman: a stronger-than-feared bank read-through would help investment banking and trading names that are currently being punished for the same volatility premium. Conversely, a downside surprise from JPM would likely hit Morgan Stanley harder on the positioning side because the market is already leaning cautious there; the group has less room to absorb a disappointingly soft NII or worse-than-expected credit language. In other words, JPM is the bellwether that can either validate the sector drawdown as a buying opportunity or turn it into a deeper de-rating.

The most underappreciated risk is that the market is conflating short-term AI investment drag with a longer-term efficiency benefit. If management frames AI spend as an earnings headwind without giving a credible path to incremental revenue or expense leverage over the next 12-24 months, the stock may underperform even on an in-line quarter. On the flip side, if capital markets revenue holds up and provisions remain contained, the recent pullback in the shares can reverse quickly because positioning is already defensive and the implied move is elevated relative to realized post-earnings volatility.

Consensus seems to be underpricing asymmetry in the options market: this is a cleaner catalyst for a volatility expression than a directional common-stock bet. The best risk/reward is to express a near-dated earnings move while avoiding outright duration risk if management disappoints on forward NII or credit. The broader message is that bank stocks are now trading on narrative credibility, not just EPS, and JPM is the most important narrative test in the group.

Key Decisions for Investors

• Buy JPM weekly straddle or strangle into earnings if implied move remains near 4%; monetize volatility if the post-print realized move exceeds the stock's recent average and avoid directional exposure to guidance risk.
• If you want directional exposure, prefer a small JPM call spread only on confirmation that NII guidance is stable; target a 2-3 week horizon with defined downside, since a miss on credit commentary could compress the multiple quickly.
• Pair trade: long GS / short MS into the print as a relative-play on a stronger capital-markets read-through if JPM’s commentary is constructive; this benefits from the market rewarding higher beta and penalizing more cautious stance.
• If JPM guides conservatively on provisions, use any post-earnings selloff to add to JPM over 3-6 months; the setup argues for mean reversion once the market stops discounting peak uncertainty.
• Hedge sector exposure with short KBE or XLF against long JPM common if holding through the event; this isolates idiosyncratic franchise strength while reducing macro bank-beta risk.